COLLEEN THORNTON: Open Payments
NPI 1760717193 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 57 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,371
Food & beverage: $1,293Education: $78
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $177 |
| Novartis Pharmaceuticals Corporation | 8 | $163 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| ABBVIE INC. | 8 | $151 |
| Stemline Therapeutics Inc. | 2 | $68 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| Rigel Pharmaceuticals, Inc. | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Genentech USA, Inc. | 1 | $35 |
Products named: KISQALI, JAKAFI, EMRELIS, JEMPERLI, TAVALISSE, Orserdu, RYBREVANT, LYNPARZA.
Industry payments across AK — which companies pay providers there.
